Filing metadata

Accession number
0000950170-24-000407
Form type
Form 3
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Jan 02, 2024
Reporting period
Jan 01, 2024
Description
Initial ownership

Explore SEC Filings Hub